1[1]Katz AM. Metabolism of the failing heart[J]. Cardioscience, 1993,4(4):199-203.
2[2]Neubauer S, Krahe T, Schindler R, et al. 31P magneticl resonamce spectroscopy in dilated cardiomyopathy and coronary artery disease: alteredcardiac high-energy phosphate metabolism in heart failure [J].Circulation, 1992, 86:1810-8.
3[3]Weiss RG, Bottomley PA, Hardy CJ. Regional myocardial metabolism ofhigh energy phosphates during isometric exercise in patients withcoromary ertery disease[J]. N Engl J Med, 1990, 323(23):1593-600.
4[4]Andreev NA, Andreeva TN, Bichkov IV. Effect of phosphocreatine incongestive heart failure [ J ]. Curr Ther Res 1992, 51 (5): 694-660.
5[5]Ferraro S, Codella C, Palumbo F, et al. Hemodynamic effects of creatinephosphate in patients with congetive heart failure: A double-blindcomparison trial versus placebo[J]. Clin Cardiol, 1996, 19: 699-703.
7Wouters K A, Kremer 1. C, Miller T L, et al. Protecting against anthracycline induced myocardial damage: a review of the most promising strategies[J]. Br J Haematol,2005,131(5) :561-578.
8I.ipshultz S E, Lipsitz S R, Sallan S E, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for children acute lymphoblastic leulcemia[J].J Clin Oncol,2005,23(12) :2629- 2636.
9Neubauer S,Kraher T,Schindler R,et al.31P-magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease.Altered cadiac high energy phosphate metabolites in heart failure[J].Circulation,1992,86(6):1810-1818.
10Sergio F,Linzia C,Fibrazio P,et al.Hemodynamic effects of phosphate in patients with congestive heart failure,A double-blind comparison trial versus placebo[J].Clin Cardiol,1996,19(9):699-703.
